Home Cart Sign in  
Chemical Structure| 487-52-5 Chemical Structure| 487-52-5

Structure of Butein
CAS No.: 487-52-5

Chemical Structure| 487-52-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Butein, a plant polyphenol isolated from Rhus verniciflua, is able to inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, also inhibits EGFR.

Synonyms: 2’,3,4,4’-tetrahydroxy Chalcone

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Butein

CAS No. :487-52-5
Formula : C15H12O5
M.W : 272.25
SMILES Code : OC1=CC=C(C(/C=C/C2=CC(O)=C(O)C=C2)=O)C(O)=C1
Synonyms :
2’,3,4,4’-tetrahydroxy Chalcone
MDL No. :MFCD00017300
InChI Key :AYMYWHCQALZEGT-ORCRQEGFSA-N
Pubchem ID :5281222

Safety of Butein

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Butein

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Description
Butein is a cAMP-specific PDE inhibitor with an IC50 of 10.4 μM for PDE4[1].
Target
  • EGFR/ErbB1

In Vitro:

Cell Line
Concentration Treated Time Description References
HepG2 10-60 μM 24-96 h Inhibited cell proliferation and colony formation, induced G2/M arrest and apoptosis PMC6158728
Primary cultured astrocytes 50 µM 4 h Inhibited TNF-α-induced pro-inflammatory mediator expression PMC10481574
Huh-7 10-60 μM 24-96 h Inhibited cell proliferation and colony formation PMC6158728
HBE cells 20 μM, 40 μM, 60 μM 24 h or 48 h Butein significantly decreased HBE cell viability. PMC6643215
Hep3B 10-60 μM 24-96 h Inhibited cell proliferation and colony formation, induced G2/M arrest and apoptosis PMC6158728
C3H10T1/2 adipocytes 20 μM 6 h Induction of Ucp1 mRNA expression, increased mitochondrial contents, and decreased numbers of large lipid droplets PMC4912433
HCC-1569 10 μg/ml 24 h To evaluate the effect of Butein on apoptosis of breast cancer cells, results showed that Butein induced apoptosis in HCC-1569 cells PMC4064524
BT-474 10 μg/ml 24 h To evaluate the effect of Butein on apoptosis of breast cancer cells, results showed that Butein induced apoptosis in BT-474 cells PMC4064524
HCC-2218 1 ng/ml to 100 μg/ml 48 h To evaluate the effect of Butein on the viability of breast cancer cells, results showed that Butein did not significantly affect the viability of HCC-2218 cells PMC4064524
HCC-1419 1 ng/ml to 100 μg/ml 48 h To evaluate the effect of Butein on the viability of breast cancer cells, results showed that Butein did not significantly affect the viability of HCC-1419 cells PMC4064524
SKBR-3 1 ng/ml to 100 μg/ml 48 h To evaluate the effect of Butein on the viability of breast cancer cells, results showed that Butein did not significantly affect the viability of SKBR-3 cells PMC4064524
T47D 1 ng/ml to 100 μg/ml 48 h To evaluate the effect of Butein on the viability of breast cancer cells, results showed that Butein reduced the viability of T47D cells PMC4064524
MCF-7 1 ng/ml to 100 μg/ml 48 h To evaluate the effect of Butein on the viability of breast cancer cells, results showed that Butein reduced the viability of MCF-7 cells PMC4064524
H1299 cells 20 μM, 40 μM, 60 μM 24 h or 48 h Butein significantly decreased NSCLC cell viability and induced cell apoptosis and G2/M phase arrest. PMC6643215
SPC-A1 cells 20 μM, 40 μM, 60 μM 24 h or 48 h Butein significantly decreased NSCLC cell viability and induced cell apoptosis and G2/M phase arrest. PMC6643215
PC-9 cells 20 μM, 40 μM, 60 μM 24 h or 48 h Butein significantly decreased NSCLC cell viability and induced cell apoptosis and G2/M phase arrest. PMC6643215
A549 cells 20 μM, 40 μM, 60 μM 24 h or 48 h Butein significantly decreased NSCLC cell viability and induced cell apoptosis and G2/M phase arrest. PMC6643215
C3H10T1/2 adipocytes 20 μM 6 h To investigate the effect of Butein on the PI3Kα-Akt1 signaling pathway, results showed that Butein increased Prdm4 and Ucp1 expression by inhibiting PI3Kα activity. PMC6115456
Hepatoma cells (HepG2) 1-10 μM 24 h Butein protected HepG2 cells against ethanol- or acetaldehyde-induced toxicity and inhibited ROS production. PMC3575555
Hepatic stellate cells (CFSC-2G) 1-10 μM 24 h Butein protected hepatic stellate cells against ethanol- or acetaldehyde-induced toxicity, inhibited ROS production, and suppressed α-SMA and procollagen I production. PMC3575555
Primary mouse hippocampal neurons 5 or 10 μM 24 h Butein decreased glutamate-induced oxidative damage and ROS production in primary mouse hippocampal neurons. PMC5055139
BV2 microglial cells 1-10 μM 12-24 h Butein suppressed LPS-induced pro-inflammatory enzymes and mediators in BV2 microglia, including IL-6, IL-1β, and TNF-α production and mRNA expression. PMC5055139
HT22 mouse hippocampal cells 1-10 μM 12-24 h Butein decreased glutamate-induced oxidative injury and ROS production in HT22 cells and increased the expression of Bcl-2 and Bcl-xL. PMC5055139
H9c2 cardiomyoblasts 1, 3, 5 µM 24 h To assess the protective effect of Butein against H2O2-induced oxidative stress. Butein pretreatment significantly increased the survival rate of H2O2-treated cells, reduced ROS production and apoptosis, and increased the expression of antioxidant proteins. PMC9331242
H9c2 cardiomyoblasts 0.5-10 µM 24, 48, 72 h To evaluate the cytotoxicity of Butein on H9c2 cardiomyoblasts. Results showed that all concentrations and durations of Butein treatment did not significantly alter cell viability. PMC9331242

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Breast cancer xenograft model Subcutaneous injection 10 μg/ml Twice a week for 20 days To evaluate the effect of Butein on in vivo breast cancer tumor growth, results showed that Butein inhibited the growth of BT-474 tumors but had no significant effect on HCC-1419 tumor growth PMC4064524
Nude mice HCC xenograft model Oral 10 mg/kg Once daily for several weeks Inhibited tumor growth and decreased expressions of Ki67 and phosphor-histone H3 PMC6158728
Nude mice PC-9 xenograft model Intraperitoneal injection 10 mg/kg Once daily for 28 days Butein significantly inhibited the growth of PC-9 xenografts by activating ER stress-dependent ROS generation and apoptosis pathways. PMC6643215
C57BL/6J mice High-fat diet-induced obese mouse model Intraperitoneal injection 5 mg/kg or 15 mg/kg per day Once daily for 8 weeks To investigate the effect of Butein on body weight gain and metabolism in high-fat diet-induced obese mice, results showed that Butein significantly reduced body weight gain and improved metabolic profiles. PMC6115456

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.67mL

0.73mL

0.37mL

18.37mL

3.67mL

1.84mL

36.73mL

7.35mL

3.67mL

References

 

Historical Records

Categories